Author:
Tham Kathryn A.,Seah Davinia S. E.
Publisher
Springer International Publishing
Reference51 articles.
1. Alsirafy SA, Sroor MY, Al-Shahri MZ. Hypercalcemia in advanced head and neck squamous cell carcinoma: prevalence and potential impact on palliative care. J Support Oncol. 2009;7(5):154–7.
2. Ayuk J, Gittoes N, Acknowledgements. Primary hyperparathyroidism. http://bestpractice.bmj.com/best-practice/monograph/133/basics/epidemiology.html . (n.d.). Accessed 28 Feb 2017.
3. Barton A, Fuller R, Dudley N. Using subcutaneous fluids to rehydrate older people: current practices and future challenges. QJM Int J Med. 2004;97(11):765–8. https://doi.org/10.1093/qjmed/hch119 .
4. Binstock ML, Mundy GR. Effect of calcitonin and glucocorticoids in combination on the hypercalcemia of malignancy. Ann Intern Med. 1980;93(2):269–72.
5. Body J-J, Bone HG, de Boer RH, Stopeck A, Van Poznak C, Damião R, Fizazi K, et al. Hypocalcaemia in patients with metastatic bone disease treated with denosumab. Eur J Cancer (Oxford, England: 1990). 2015;51(13):1812–21. https://doi.org/10.1016/j.ejca.2015.05.016 .